Speech-Language Pathologists in Bixby, OK Accepting Medicare

27 Speech-Language Pathologists found. Showing 21 - 27

Joan Marie Hughes, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11644 S 102nd East Ave, Bixby, OK 74008 Phone: 918-638-9673    Fax: 918-970-2951

Mrs. Beki Michele Mitchell, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2026 E 140th Pl S, Bixby, OK 74008 Phone: 918-366-3320

Christina M Bell, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11986 S 91st East Ave, Bixby, OK 74008 Phone: 918-691-4937

Lana Neafus Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3632 E 143rd St S, Bixby, OK 74008 Phone: 918-633-0940

Mrs. Amanda Kay Gammill, M.S CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9401 E 161st St S, Bixby, OK 74008 Phone: 918-366-2249

Aday Of Speech Therapy L.l.c. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5822 E 145th St S, Bixby, OK 74008 Phone: 602-377-6542

Jessica Thompson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7701 E. 121st, Bixby, OK 74008 Phone: 918-409-8205

News Archive

Mitrionics' Accelerated Computing Platform selected by QUT for accelerating algorithms

Mitrionics AB, the technology leader in FPGA-based hybrid computing, today announced that the Queensland University of Technology (QUT) High Performance Computing group has selected the Mitrion™ Accelerated Computing Platform to explore several projects designed to accelerate algorithms in different application areas.

Accumulation of passenger mutations can slow or even halt tumor growth

A typical cancer cell has thousands of mutations scattered throughout its genome and hundreds of mutated genes. However, only a handful of those genes, known as drivers, are responsible for cancerous traits such as uncontrolled growth. Cancer biologists have largely ignored the other mutations, believing they had little or no impact on cancer progression.

New precise method for studying the DNA binding of small molecules

Northeastern University professor Mark C. Williams and colleague Ioana Vladescu have discovered a novel method for studying the DNA binding of small molecules with unprecedented accuracy.

Home-based intervention benefits dementia patients and caregivers

An intervention that targeted modifiable stressors in the home of patients with dementia resulted in better outcomes for the patients and their caregivers at 4 months, but not at 9 months, although the caregivers perceived greater benefits, according to a study in the September 1 issue of JAMA.

Micell announces preliminary data from MiStent Sirolimus DES clinical study

Micell Technologies, Inc. today announced the release of preliminary data from the first-in-human clinical study of the MiStent Sirolimus Drug Eluting Coronary Stent System (MiStent DES), a thin-strut drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating designed for controlled drug release.

Read more Medical News

› Verified 2 days ago

• 1
• 2(current)